Specific immune response to human immunodeficiency virus (HIV)-1 in patients assessed through the production of interferon-γ and interleukin-4 in HIV-1 p24-activated whole blood cultures: Relationship with the viral load in plasma

Scandinavian Journal of Immunology

Volumn 50, Issue 1, 1999, Pages 83-90

  Hober, Didier ^a   Benyoucef, S ^a   Chieux, V ^a   De Groote, D ^d   De La Tribonniere X ^b   Bocket, L ^a   Lion, G ^c   Mouton, Y ^b   Wattre P ^a  

^a CHU Rouen BG   (France)

^b CENTRE HOSPITALIER   (France)

^c CENTRE HOSPITALIER DE VALENCIENNES   (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; GAMMA INTERFERON; INTERLEUKIN 4; MITOGENIC AGENT; VIRUS RNA;

ARTICLE; BLOOD CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MITOGENS; RNA, VIRAL; VIRAL LOAD;

EID: 0033053525     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00564.x     Document Type: Article

References (41)

1. 1 Paul WE. Pleiotropic and redundancy: T-cell-derived lymphokines in the immune response. Cell 1989;57:521-4.
2. 2 Balkwill FR, Burke F. The cytokine network. Immunol Today 1989;10:299-304.
3. 3 Jacob CO. TNF and IFN-gamma: relevance for immune regulation and genetic predisposition to autoimmune disease. Semin Immunol 1993;3:147-54.
4. 4 Clerici M, Schearer GM. A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-11.
5. 5 Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Moroni PL. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994;8:757-62.
6. 6 Clerici M, Hakim FT, Venzon DJ, Blatt SP, Hendrix CW, Wynn TA, Shearer GM. Changes in interleukin 2 and interleukin 4 production in asymptomatic, HIV-scropositive individuals. J Clin Invest 1993;91:759-65.
7. 7 Graziosi C, Pantaleo G, Ganett KR, Demarest O, Cohen OJ, Fauci AS. Constitutive expression of cytokines in lymphoid tissue of HIV-infected individuals: lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 1994;265:248-52.
8. 8 Maggi E, Mazzetti M, Ravina A, Annunzita M, De Carli M, Piccini P, Manetti MP, Carbonari M, Pesce AM, Del Prete G, Romagnani S. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 1994;265:244-8.
9. 9 Lolli F, Chen LB, Sundqvist VA, Link H, Holmberg V, Wahren B. HIV antigen-reactive cells detected by antigen-induced interferon-γ secretion. AIDS Res Hum Retroviruses 1994;10:115-19.
10. 10 Benyoucef S, Hober D, De Groote D, La Tribonnière X, Vilain V, Lion G, Bouzidi A, Wattré P. An interferon-γ (IFN-γ)-based whole blood assay to detect T cell response to antigens in HIV-1 infected patients. Pathol Biol 1997;45:400-3.
11. 11 Benyoucef S, Hober D, De Groote D, De Bocket L, La Tribonnière X, Mouton Y, Wattré P. RANTES production in HIV1-antigen-stimulated whole blood culture: relationship with type 1 immune response and plasma viral load in HIV-1 infected individuals. Scand J Immunol 1998;48:212-16.
12. 12 Connors RI, Mohri H, Ho D. Increased viral burden and cytopathicity correlate temporally with CD4 + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 1993;67:1772-7.
13. 13 Koot M, Keet IPM, Vos AHV, De Goede R. Roos MTHL, Coutinho RA, Miedema F, Shelleken PTHA, Tersmette M. Prognosic value of human immunodeficiency virus type 1 biological phenotype for rate of CD4 depletion and progression to AIDS. Ann Intern Med 1993;118:681-8.
14. 14 Vigano A, Ballota C, Trabattoni D, Salvaggio A, Riva C, Bricalli D, Crupi L, Colombo MC, Principle N, Galli M, Clerici M. Virological and immunological markers of disease progression in pediatric HIV infection. AIDS Res Hum Retroviruses 1996;12: 1255-62.
15. 15 Clerici M, Ballota C, Salvaggio A, Riva C, Trabattoni D, Papagno L, Berlusconi A, Rusconi Villa ML, Moroni M, Galli M. Human immunodeficiency virus (HIV) phenotype and interleukin-2/interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 1996;88:574-9.
16. 16 Paul DA, Falk LA, Kessler HA. Correlation of serum HIV antigen and antibody with clinical status in HIV-infectcd patients. J Med Virol 1987;22:357-63.
17. 17 Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
18. 18 Iuliano R, Forastieri G, Brizzi M, Mecocci L, Mazzotta F, Ceccherini-Nelli L. Correlation between plasma HIV-1 RNA levels and the rate of immunological decline. J Acquired Immunodeficiency Syndromes Hum Retrovirol 1997;14:408-14.
19. 19 Klein MR, Van Baalen CA. Kinetics of Gag-specific CTL responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1365-72.
20. 20 Gomez AM, Smail FM, Rosenthal KL. Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stages of disease. Clin Exp Immunol 1994;97:68-75.
21. 21 Höiden I, Möller G. CD8+ cells are the main producers of IL-10 and IFN-γ after superantigen stimulation. Scand J Immunol 1996;44: 501-5.
22. 22 Manetti R, Annunziato F, Biagiotti R. CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for a large number of CD8 + CD30+ T cell clones in human immunodeficiency virus infection. J Infect Dis 1994;180:2407-11.
23. 23 Zanussi S, Simonelli C, D' Andrea M, Caffau C, Clerici M, Tirelli U, De Paoli P. CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection. Clin Exp Immunol 1996;105:220-4.
24. 24 Jassoy C, Harrer T, Rosenthal T, Navia BA, Worth J, Johnson RP, Walker BD. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor (TNF-α), and TNF-β when they encounter their target antigens. J Virol 1993;67:2844-52.
25. 25 Center for Disease Control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993;1-19.
26. 26 Hober D, Lucas B, Wattré P, Capron A, Haque A. TNF-α production by U937 promonocytes is enhanced by factors released from HIV-infected T lymphocytes: TNF-α is one of the mediators causing HIV-infected T4 cells lysis. Clin Immunol Immunopathol 1992;62: 168-75.
27. 27 Leroux M, Schindler L, Braun R, Doerr HW, Geisen HP, Kirchner H. A whole blood lymphoproliferation assay for measuring cellular immunity against herpes viruses. J Immunol Methods 1985;79:251-62.
28. 28 Fiavey NP, Frankenberg S. Appraisal of the total blood lymphocyte proliferation assay as a diagnosis tool in screening for tuberculosis. J Med Microbiol 1992;37:283-5.
29. 29 Weir RE, Morgan AR, Britton WJ, Butlin CR, Dockrell HM. Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiologieal field studies of leprosy immunity. J Immunol Methods 1994;176:93-101.
30. 30 Daynes RA, Araneo BA. Natural regulators of T-cell lymphokine production in vitro. J Immunother 1992;12:174-9.
31. 31 Petrovsky N, Harrison LC. Cytokine-based human whole blood assay for the detection of antigen-reactive T cells. J Immunol Methods 1995;186:37-46.
32. 32 De Groote D, Zangerle PF, Gevaert Y, Fassotte MF, Beguin Y, Franchimont P. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IFN-gamma and GM-CSF) in whole blood I. Comparison with isolated PBMC stimulation. Cytokine 1992;4:239-48.
33. 33 Goudsmit J, De Wolf F, Paul DA, Lang JMA, Speelman H, Van Der Noordaa J, Van Der Helm H, Epstein LG, Krone WJA, Wolters EC, Oleske JM, Coutinho RA. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infections. Lancet 1986;2:177-9.
34. 34 Breen EC, Salazar-Gonzalez JF, Shen LP, Kolberg JA, Urdea MS, Martin'ez-Maza O, Fahey JL. Circulating CD8 T cells show increased interferon-gamma mRNA expression in HIV infection. Cell Immunol 1997;178:91-8.
35. 35 Meyaard L, Hovenkamp E, Keet IPM, Hooibrink B, De Jong IH, Otto SA, Miedema F. Single-cell analysis of IL-4 and IFN-γ production by T cells from HIV-infected individuals. J Immunol 1996;157:2712-18.
36. 36 Westby M, Marriott JB, Guckian M, Cookson S, Hay P, Dalgleish AG. Abnormal intracellular IL-2 and interferon-gamma (IFN-gamma) production as HIV-1-associated markers of immune dysfunction. Clin Exp Immunol 1998;11:257-63.
37. 37 Forster MS, Osborne LM, Chiengson-Popov RF. Decline of anti-p24 antibody precedes antigenemia as correlate to prognosis in HIV-1 infection. AIDS 1987;1:235-40.
38. 38 Pontesilli O, Carlesimo M, Varani AR, Ferrara R, D'Offizi G, Aiuti F. In vitro lymphocyte proliferative response to HIV-1 p24 is associated with a lack of CD4+ cell decline. AIDS Res Hum Retroviruses 1994;10:113 -14.
39. 39 Riviere Y, McChesney M, Porrot F, Tanneau-Salvadori F, Sansonetti P, Lopez O, Pialoux G, Feuillie V, Mollereau M, Chamaret S, Tekaia F, Montagnier L. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-Related Complex or AIDS. AIDS Res Hum Retroviruses 1995;3:125-33.
40. 40 Pontesilli O, Klein MR, Kerkhof-Garde SR, Pakker NG, de Wolg F, Schuitemaker H, Miedema F. Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection. J Infect Dis 1998;178:1008-18.
41. 41 Hartshom K, Neumeyer D, Vogt M, Schooley R, Hirsh M. Activity of interferons alpha, beta and gamma against human immunodeficiency virus replication in vitro. AIDS Res Hum Retroviruses 1987;3:125-33.